Brez internetne povezave — prikazana je shranjena različica strani.

Organon & Co

USUSD
← Na Filter Delnic

Organon & Co (LSE:0A9W) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 2. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
organon.com
Odnosi z Vlagatelji
organon.com/investor-relations/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
Oss, United States
Izvršni Direktor
Joseph T. Morrissey
Zaposleni
10 000
Ustanovljena
1923
Delnice v Obtoku
262.61 mio. na dan 2026-07-24
1 Leto: +1.0% · 3 leta: +2.8% · 5 let: +3.6% (brez razcepov delnic)
DatumDelniceSprememba
24.07.2026262.61 mio.—brez bistvenih sprememb
27.04.2026262.6 mio.+0.9%izdaja (razredčitev)
17.02.2026260.32 mio.+0.1%izdaja (razredčitev)
03.11.2025259.98 mio.—brez bistvenih sprememb
30.07.2025259.97 mio.—brez bistvenih sprememb
25.04.2025259.96 mio.+0.8%izdaja (razredčitev)
25.02.2025257.95 mio.+0.2%izdaja (razredčitev)
25.10.2024257.54 mio.+0.03%brez bistvenih sprememb
30.07.2024257.47 mio.+0.1%izdaja (razredčitev)
26.04.2024257.17 mio.+0.6%izdaja (razredčitev)
20.02.2024255.64 mio.+0.01%brez bistvenih sprememb
27.10.2023255.61 mio.+0.01%brez bistvenih sprememb
04.08.2023255.57 mio.+0.2%izdaja (razredčitev)
28.04.2023255.06 mio.+0.3%izdaja (razredčitev)
22.02.2023254.38 mio.—brez bistvenih sprememb
Število delnic po poročilih podjetja. Razcep se prepozna po skoku števila za celo število krat.
Prosto Prenosljive Delnice
242.99 mio.
Tržna Kapitalizacija
3.6 mrd. USD
Notranje Osebe
0.46%
Institucionalni Vlagatelji
84.8%
Panoga (SIC)
Pharmaceutical Preparations
ISIN
US68622V1061
LEI
549300AMCKY57OK2CO56
Delež Izplačila
8.6%
FCF
567 mio. USD
Izplačilo / FCF
3%
Dolg
8.55 mrd. USD
13 let FCF
Dividendni Staž
5 let
Dobički, FCF in izplačane dividende — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
NAV
3.83 USD · P/NAV 3.58
Datum Bilance Stanja30.06.2026
Sredstva13.2 mrd. USD
− Obveznosti12.2 mrd. USD
= NAV (lastniški delež delničarjev podjetja)1.01 mrd. USD
− Dobro Ime4.15 mrd. USD
− Neopredmetna Sredstva1.11 mrd. USD
= Opredmetena NAV−4.26 mrd. USD
Delnice262 609 000
NAV na Delnico3.83 USD
Otipljiv NAV na Delnico−16.22 USD
Cena Delnice (0A9W)13.7300 USD
P/NAV3.58
Zgodovina NAV
Datum Bilance StanjaNAVNAV na Delnico
30.06.20261.01 mrd. USD3.83 USD
31.03.2026903 mio. USD3.44 USD
31.12.2025752 mio. USD2.89 USD
30.09.2025906 mio. USD3.48 USD
30.06.2025733 mio. USD2.82 USD
31.03.2025542 mio. USD2.10 USD
31.12.2024472 mio. USD1.83 USD
30.09.2024493 mio. USD1.91 USD
Opis

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksOGN glavnaUSD13.74 -0.22%navadne delnice
LSE London Stock Exchange0A9W IOBUSD13.73 +0.07%navadne delnice

Cena v 3 Mesecih

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Na leto, LSE:0A9W: 0.08 USD (4 izpl.)

Organon & Co (0A9W) izplačuje dividende četrtletno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 0.08 USD na delnico (plačila: 4). To je približno 0.58% trenutne cene delnice. Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 17.11.2026. Leta neprekinjenih dividend: 5.

Ex-DatumIzplačiloZnesek%VrstaOznaka
2026-08-142026-09-100.0200 USD0.1/0.6 %četrtletnoLSE:0A9W
2026-05-112026-06-110.0200 USD0.2/0.6 %četrtletnoLSE:0A9W
2026-02-232026-03-120.0200 USD0.3/1.0 %četrtletnoLSE:0A9W
2025-11-202025-12-110.0200 USD0.3/4.6 %četrtletnoLSE:0A9W
2025-08-152025-09-110.0200 USD0.2/6.5 %četrtletnoLSE:0A9W
2025-05-122025-06-120.0200 USD0.2/9.7 %četrtletnoLSE:0A9W
2025-02-212025-03-130.2800 USD1.8/7.2 %četrtletnoLSE:0A9W
2024-11-122024-12-120.2800 USD1.5/6.0 %četrtletnoLSE:0A9W
2024-08-162024-09-120.2800 USD1.5/6.0 %četrtletnoLSE:0A9W
2024-05-102024-06-130.2800 USD1.5/6.0 %četrtletnoLSE:0A9W
2024-02-232024-03-140.2800 USD1.5/6.0 %četrtletnoLSE:0A9W
2023-11-102023-12-140.2800 USD2.4/9.8 %četrtletnoLSE:0A9W
2023-08-17—0.2800 USD1.2/4.9 %četrtletnoLSE:0A9W
2023-05-12—0.2800 USD1.3/5.3 %četrtletnoLSE:0A9W
2023-02-24—0.2800 USD1.1/4.2 %četrtletnoLSE:0A9W
2022-11-10—0.2800 USD1.2/4.7 %četrtletnoLSE:0A9W
2022-08-12—0.2800 USD0.9/3.5 %četrtletnoLSE:0A9W
2022-05-13—0.2800 USD0.8/2.4 %četrtletnoLSE:0A9W
2022-02-25—0.2800 USD0.8/1.6 %četrtletnoLSE:0A9W
2021-11-19—0.2800 USD0.9/0.9 %četrtletnoLSE:0A9W

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
Blackrock Inc.12.21%32.06 mio.2026-06-30
Pentwater Capital Manage…6.89%18.1 mio.2026-06-30
iShares Trust-iShares Co…6.09%16 mio.2026-08-31
Vanguard Portfolio Manag…5.76%15.13 mio.2026-06-30
Vanguard Capital Managem…4.54%11.91 mio.2026-06-30
State Street Corporation3.68%9.66 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%8.33 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.29%6.02 mio.2026-06-30
Goldman Sachs Group Inc1.98%5.2 mio.2026-06-30
UBS Group AG1.85%4.86 mio.2026-06-30
Geode Capital Management…1.83%4.82 mio.2026-06-30
Alliancebernstein L.P.1.81%4.75 mio.2026-06-30
Man Group PLC1.59%4.18 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…1.45%3.82 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…1.15%3.01 mio.2026-06-30
NexPoint Funds I-NexPoin…1.03%2.71 mio.2026-06-30
SPDR SERIES TRUST-State…0.94%2.47 mio.2026-08-31
iShares Trust-iShares S&…0.89%2.35 mio.2026-08-31
SPDR SERIES TRUST-State…0.54%1.41 mio.2026-08-31
Fidelity Concord Street…0.49%1.3 mio.2026-07-31
ALI KEVIN (Chief Executi…≈0.11%282 7312025-05-05
WALSH MATTHEW M (Chief F…≈0.08%212 7462026-03-31
MORRISSEY JOSEPH T JR (C…≈0.05%123 1232026-03-31
STAHLER RACHEL A (Chief…≈0.04%116 1052026-03-31
FALCIONE AARON (Officer)≈0.04%101 4312026-03-31
WEAVER KIRKE (General Co…≈0.04%92 6392026-03-31
NISITA VITTORIO (Officer…≈0.03%70 6192026-03-31
KARP DANIEL (Officer)≈0.03%69 5472026-03-31
HOLZBAUR LYNETTE (Office…≈0.02%52 8502026-05-06
COX CARRIE SMITH (Office…——2025-11-12